Metabolic Reprogramming of Chemoresistant Cancer Cells and the Potential Significance of Metabolic Regulation in the Reversal of Cancer Chemoresistance
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Metabolic Reprogramming of Chemoresistant Cancer Cells and the Potential Significance of Metabolic Regulation in the Reversal of Cancer Chemoresistance
Authors
Keywords
-
Journal
Metabolites
Volume 10, Issue 7, Pages 289
Publisher
MDPI AG
Online
2020-07-22
DOI
10.3390/metabo10070289
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Phosphoglycerate dehydrogenase promotes proliferation and bortezomib resistance through increasing reduced glutathione synthesis in multiple myeloma
- (2020) Xuan Wu et al. BRITISH JOURNAL OF HAEMATOLOGY
- REDD1 loss reprograms lipid metabolism to drive progression of RAS mutant tumors
- (2020) Shuxi Qiao et al. GENES & DEVELOPMENT
- Metabolic reprogramming and cancer progression
- (2020) Brandon Faubert et al. SCIENCE
- Retrodifferentiation of human tumor hepatocytes to stem cells leads to metabolic reprogramming and chemoresistance
- (2019) Karim Fekir et al. CANCER RESEARCH
- 6PGD inhibition sensitizes hepatocellular carcinoma to chemotherapy via AMPK activation and metabolic reprogramming
- (2019) Hu Chen et al. BIOMEDICINE & PHARMACOTHERAPY
- Cisplatin resistance involves a metabolic reprogramming through ROS and PGC-1α in NSCLC which can be overcome by OXPHOS inhibition
- (2019) Alberto Cruz-Bermúdez et al. FREE RADICAL BIOLOGY AND MEDICINE
- Cysteine dioxygenase 1 is a metabolic liability for non-small cell lung cancer
- (2019) Yun Pyo Kang et al. eLife
- The Non-Essential Amino Acid Cysteine Becomes Essential for Tumor Proliferation and Survival
- (2019) Joseph A. Combs et al. Cancers
- Adipocyte and lipid metabolism in cancer drug resistance
- (2019) Yihai Cao JOURNAL OF CLINICAL INVESTIGATION
- Dietary methionine influences therapy in mouse cancer models and alters human metabolism
- (2019) Xia Gao et al. NATURE
- Metabolic reprogramming and redox adaptation in sorafenib-resistant leukemia cells: detected by untargeted metabolomics and stable isotope tracing analysis
- (2019) Xin You et al. Cancer Communications
- An arginase-based system for selection of transfected CHO cells without the use of toxic chemicals
- (2019) Berta Capella Roca et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Mechanisms of acquired tumor drug resistance
- (2019) Svetlana N. Aleksakhina et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Understanding of ROS-Inducing Strategy in Anticancer Therapy
- (2019) Su Ji Kim et al. Oxidative Medicine and Cellular Longevity
- Metabolic Alterations in Pancreatic Cancer Progression
- (2019) Enza Vernucci et al. Cancers
- Cysteine boosters the evolutionary adaptation to CoCl2 mimicked hypoxia conditions, favouring carboplatin resistance in ovarian cancer
- (2018) Sofia C. Nunes et al. BMC EVOLUTIONARY BIOLOGY
- A Metabolomic Approach to Predict Breast Cancer Behavior and Chemotherapy Response
- (2018) Marcella Cardoso et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Molecular targeting of glutaminase sensitizes ovarian cancer cells to chemotherapy
- (2018) Chioniso P. Masamha et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Preliminary evaluation of the potential role of β‑elemene in reversing erlotinib‑resistant human NSCLC A549/ER cells
- (2018) Lan Lin et al. Oncology Letters
- Reprogrammed lipid metabolism in bladder cancer with cisplatin resistance
- (2018) Min Young Lee et al. Oncotarget
- Cysteine allows ovarian cancer cells to adapt to hypoxia and to escape from carboplatin cytotoxicity
- (2018) Sofia C. Nunes et al. Scientific Reports
- Ibrutinib Resistance Is Reduced by an Inhibitor of Fatty Acid Oxidation in Primary CLL Lymphocytes
- (2018) Gabriela Galicia-Vázquez et al. Frontiers in Oncology
- Overcoming Drug Resistance through the Development of Selective Inhibitors of UDP-Glucuronosyltransferase Enzymes
- (2018) Michael J. Osborne et al. JOURNAL OF MOLECULAR BIOLOGY
- Reversal of multidrug resistance in breast cancer cells by a combination of ursolic acid with doxorubicin
- (2018) Li Zong et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Impact of chemotherapy on metabolic reprogramming: Characterization of the metabolic profile of breast cancer MDA-MB-231 cells using 1 H HR-MAS NMR spectroscopy
- (2017) Roberta M. Maria et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- A novel 5-fluorouracil-resistant human esophageal squamous cell carcinoma cell line Eca-109/5-FU with significant drug resistance-related characteristics
- (2017) Chi Zhang et al. ONCOLOGY REPORTS
- Correction: MUC1 facilitates metabolomic reprogramming in triple-negative breast cancer
- (2017) Gennifer Goode et al. PLoS One
- Comparative metabolomic analysis of HPAC cells following the acquisition of erlotinib resistance
- (2017) Sooyeun Lee et al. Oncology Letters
- Multi-omics analysis reveals that ornithine decarboxylase contributes to erlotinib resistance in pancreatic cancer cells
- (2017) Won-Jun Jang et al. Oncotarget
- Exploiting ROS and metabolic differences to kill cisplatin resistant lung cancer
- (2017) Medhi Wangpaichitr et al. Oncotarget
- Enolase 1 stimulates glycolysis to promote chemoresistance in gastric cancer
- (2017) Xiaoling Qian et al. Oncotarget
- The Glycolytic Switch in Tumors: How Many Players Are Involved?
- (2017) Li Yu et al. Journal of Cancer
- Metabolic reprogramming is associated with flavopiridol resistance in prostate cancer DU145 cells
- (2017) Xiaoran Li et al. Scientific Reports
- Bioenergetic Adaptations in Chemoresistant Ovarian Cancer Cells
- (2017) Sajad Dar et al. Scientific Reports
- Investigations on the cell metabolomics basis of multidrug resistance from tumor cells by ultra-performance liquid chromatography–mass spectrometry
- (2016) Ruixing Zhang et al. ANALYTICAL AND BIOANALYTICAL CHEMISTRY
- Macrophages induce resistance to 5-fluorouracil chemotherapy in colorectal cancer through the release of putrescine
- (2016) Xuan Zhang et al. CANCER LETTERS
- Identification of proteomic and metabolic signatures associated with chemoresistance of human epithelial ovarian cancer
- (2016) Wenjuan Wu et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Modulation of anti-cancer drug sensitivity through the regulation of mitochondrial activity by adenylate kinase 4
- (2016) Koichi Fujisawa et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Metabolomics Analysis of Hormone-Responsive and Triple-Negative Breast Cancer Cell Responses to Paclitaxel Identify Key Metabolic Differences
- (2016) Delisha A. Stewart et al. JOURNAL OF PROTEOME RESEARCH
- The sweet trap in tumors: aerobic glycolysis and potential targets for therapy
- (2016) Li Yu et al. Oncotarget
- Decreased glutathione biosynthesis contributes to EGFR T790M-driven erlotinib resistance in non-small cell lung cancer
- (2016) Hongde Li et al. Cell Discovery
- Rewired Metabolism in Drug-resistant Leukemia Cells
- (2015) Claudia Stäubert et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Investigating a signature of temozolomide resistance in GBM cell lines using metabolomics
- (2015) Patrick-Denis St-Coeur et al. JOURNAL OF NEURO-ONCOLOGY
- Adaptive Mitochondrial Reprogramming and Resistance to PI3K Therapy
- (2015) Jagadish C. Ghosh et al. JNCI-Journal of the National Cancer Institute
- Increased levels of choline metabolites are an early marker of docetaxel treatment response in BRCA1-mutated mouse mammary tumors: an assessment by ex vivo proton magnetic resonance spectroscopy
- (2015) Jack JA van Asten et al. Journal of Translational Medicine
- Metabolic pathways promoting cancer cell survival and growth
- (2015) Lindsey K. Boroughs et al. NATURE CELL BIOLOGY
- HNF1β drives glutathione (GSH) synthesis underlying intrinsic carboplatin resistance of ovarian clear cell carcinoma (OCCC)
- (2015) Filipa Lopes-Coelho et al. TUMOR BIOLOGY
- A metabolomic approach to identifying platinum resistance in ovarian cancer
- (2015) Laila M Poisson et al. Journal of Ovarian Research
- Inhibition of glucose-6-phosphate dehydrogenase sensitizes cisplatin-resistant cells to death
- (2015) Daniela Catanzaro et al. Oncotarget
- Adaptive Mitochondrial Reprogramming and Resistance to PI3K Therapy
- (2015) Jagadish C. Ghosh et al. JNCI-Journal of the National Cancer Institute
- Metabolomic approach to evaluating adriamycin pharmacodynamics and resistance in breast cancer cells
- (2013) Bei Cao et al. Metabolomics
- Metabolomics Reveals Metabolic Targets and Biphasic Responses in Breast Cancer Cells Treated by Curcumin Alone and in Association with Docetaxel
- (2013) Mathilde Bayet-Robert et al. PLoS One
- Cisplatin Induces a Mitochondrial-ROS Response That Contributes to Cytotoxicity Depending on Mitochondrial Redox Status and Bioenergetic Functions
- (2013) Rossella Marullo et al. PLoS One
- Targeting cellular metabolism to improve cancer therapeutics
- (2013) Y Zhao et al. Cell Death & Disease
- Silencing of GLUT-1 inhibits sensitization of oral cancer cells to cisplatin during hypoxia
- (2012) Makoto Shimanishi et al. JOURNAL OF ORAL PATHOLOGY & MEDICINE
- Metabolomic analysis of dynamic response and drug resistance of gastric cancer cells to 5-fluorouracil
- (2012) SHINSUKE SASADA et al. ONCOLOGY REPORTS
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- “Metabolic Reprogramming” in Ovarian Cancer Cells Resistant to Cisplatin
- (2011) M. Montopoli et al. CURRENT CANCER DRUG TARGETS
- Metabolic assessment of a novel chronic myelogenous leukemic cell line and an imatinib resistant subline by 1H NMR spectroscopy
- (2010) Brian J. Dewar et al. Metabolomics
- Warburg effect in chemosensitivity: Targeting lactate dehydrogenase-A re-sensitizes Taxol-resistant cancer cells to Taxol
- (2010) Ming Zhou et al. Molecular Cancer
- Time-dependent effects of imatinib in human leukaemia cells: a kinetic NMR-profiling study
- (2009) J Klawitter et al. BRITISH JOURNAL OF CANCER
- Abnormalities in Glucose Uptake and Metabolism in Imatinib-Resistant Human BCR-ABL-Positive Cells
- (2009) D. J. Kominsky et al. CLINICAL CANCER RESEARCH
- Characterization of 1H NMR detectable mobile lipids in cells from human adenocarcinomas
- (2009) Anna Maria Luciani et al. FEBS Journal
- 1H NMR Detection of Mobile Lipids as a Marker for Apoptosis: The Case of Anticancer Drug-Loaded Liposomes and Polymeric Micelles
- (2009) T. Musacchio et al. MOLECULAR PHARMACEUTICS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now